Navigation Links
Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer
Date:12/14/2008

A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.

In their studies with the fruit fly, Drosophila melanogaster, at the Mayo Clinic College of Medicine in Minnesota, scientists found a link between the "Seven-In-Absentia" or SINA gene and the aggressive cellular transformation, oncogenesis and metastasis that characterize pancreatic cancer.

Scientists already knew that a mutation in the K-RAS gene underlies the abnormal, excessive cell growth of pancreatic cancer.

Because the mutated form of this growth-promoting gene is hyperactivated, a major signaling pathway that drives cell growth is in over-drive in most patients with this cancer.

The "Seven-In-Absentia-Homolog" (SIAH) protein seems to work as a check and balance mechanism in the K-RAS pathway by chewing up and turning off the excessive growth-promoting proteins produced by the hyperactive, mutated form of the gene, says Amy Tang whose Mayo lab conducted the research.

"By attacking the SIAH-based protein degrading machinery, we block tumor formation in one of the most aggressive human cancers cells known," she reports.

Because of these results, SIAH may be an attractive new target for novel anti-RAS and anti-cancer therapy in pancreatic cancer, the median survival of which is only six months, and the mortality rate is 95 percent.

By inhibiting SIAH function, Tang and her colleagues were able to completely abolish both tumorigenesis and metastasis of human pancreatic cancer cells that were growing in "nude" mice that have immune system deficits that prevent them from rejecting foreign tissue.

"It is likely to move into the clinical setting for study as an interventiona
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
American Society for Cell Biology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Blocking Potent Oxidant Could Prevent Morphine Tolerance
2. Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
3. Blocking the effect of inflammation-causing cells lowered prostate cancer cells invasion
4. Blocking signaling protein prevents prostate cancer spread, Jefferson scientists find
5. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
6. A new molecular zip code, and a new drug target for Huntingtons disease
7. New knock-out gene model provides molecular clues to breast cancer
8. Molecular probe paints cancer cells in living animals, Stanford researchers find
9. Story ideas from molecular & cellular proteomics
10. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
11. SNM seeks novel approaches to molecular imaging to showcase at annual meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...swire/ -- HealthPlus of Michigan today announced t...ns designed for Medicare-eligible people looking f...s to quality health care. ,, HealthPlus Medica...Michigan, according to the "America,s Best Health ...p; World Report and the National Committee on Qual...
(Date:11/30/2009)...PRNewswire-USNewswire/ -- In Massachusetts, approx...cared for at home, so the Alzheimer,s Association ...line during the holiday season. For most families,...erness and sharing, but for a family dealing with ...lled with special challenges, according to the exp...
(Date:11/30/2009)...swire/ -- Kool Smiles received top honors for it...gnition as one of InfoWorld ,s Top 100 IT Proj...ark Blomquist, Kool Smiles built a Wyse-based thin...ealth records systems at 13 new dental offices acr...plete, Kool Smiles has implemented electronic heal...
(Date:11/30/2009)...wswire/ -- Mary Rita Hyland, Assistant Vice Presid... (SSI) has been elected to the 2010 Board for the ... ,, Hyland has held a variety of leadership pos...01. She was initially charged with the development...and Business Continuity for SSI. She later develop...
(Date:11/30/2009)...ant impact, CBO analysis understates the effect ,...-- The Blue Cross and Blue Shield Association (BC...estimate released today by the Congressional Budge... many economists, actuaries, and health policy exp...form bill would make coverage more expensive for m...
Breaking Medicine News(10 mins):Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:Alzheimer's Caregivers Face Holiday Stress 2Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:SSI Assistant Vice President Elected to WEDI Board 2Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2
...ademy of Pediatrics has reported that all infants,...iven vitamin D to help prevent rickets, a potentia... grow straight and strong. While breast milk is th...nlight, a natural source of the vitamin D. All inf...
...udy by researchers at St Mary's Hospital, Manchest...se is an important factor in women under 30 with b...r 30 who had been diagnosed with breast cancer sho...e found to carry// mutations in the BRCA1 or BRCA2...
...patients with viral encephalitis by researchers at... condition could cause seriouys movement problems...th the condition, five of whom had West Nile viru...onus (sudden jerking), chorea (writhing) and balli...
... by researchers at the A & A Pain Institute in St ...reduction & Algology: the study of pain), have fo...gs dramatic relief to nerve pain caused by cancer...algesic drugs were not effective in relieving the ...
... by Ohio State University researchers has shown th... attack are not being managed appropriately. The ...rt attack victims have found that patients' own d...s found that anxiety levels varied from none to se...
...n Pharmaceutical Association has given out a list ...r pleasure trips to help continue safe use of pres...e informed: A schedule of the drugs that you are t...lp you adjust to changes in time zones and changes...
Other Medicine News:
(Date:11/30/2009)... , CLEVELAND, Nov. 30 /PRNewswire-FirstCall/ ...echnology and services company focused on global e...y, today announced that PFC Pharma Focus AG (PFC) ...ave the ability to contract for DATATRAK,s CRO par...Clinical(TM) product suite. In addition, PFC will...
(Date:11/30/2009)... , BOTHELL, Wash., Nov. 30 /PRNewswire-Fir...nnounced today that on November 25, 2009, the NYSE...at it had accepted the Company,s plan to comply wi...er Section 1003(a)(iv) of the Exchange Company Gui...at the Company sustained losses which were so subs...
(Date:11/30/2009)... , MELVILLE, N.Y., Nov. 30 /PRNewswire-First... largest provider of health care products and serv...mpany,s Executive Vice President and Chief Financi...vestor Program on Tuesday, December 1, 2009. The ... London. ,, Henry Schein,s presentation is sch...
Breaking Medicine Technology:PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Henry Schein to Present at the NASDAQ OMX 23rd Investor Program 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 6514 1Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 6514 2Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 6512 1Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 6512 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV AIDS 6510 1New Report Shows 97 Medicines and Vaccines Currently in Development for HIV AIDS 6510 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV AIDS 6510 3
...ec. 21 A new brain imaging,study by researchers i...Pennsylvania shows that cigarette cravings in smok...ncreased activation in specific regions of the,bra...flow developed by John,Detre, MD, associate profes...to show how abstinence from nicotine produces brai...
...c. 21 Romark Laboratories, L.C., a,privately-owne...ng of an,$18 million institutional financing with ...ncing will enable Romark to advance,development of...t of,hepatitis C, and advance its next-generation ...patitis B and C and other viral diseases. Romark i...
Other Medicine Technology:'Brain Signature' for Cigarette Cravings Identified 2'Brain Signature' for Cigarette Cravings Identified 3
Fast-Cath Hemostasis Introducers
Bx Velocity Rx with Hepacoat
EPT-1000 XP Cardiac Ablation System
Irrigating Cannula Handpiece (Titanium)
Medicine Products: